North America Digital Therapeutics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)

No. of Pages: 127    |    Report Code: TIPRE00028839    |    Category: Technology, Media and Telecommunications

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Digital Therapeutics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Digital Therapeutics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Digital Therapeutics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Growth in chronic disease management
  • 5.1.2 Need for cost-effective therapies
5.2 Market Opportunities
  • 5.2.1 Government support for digital health
  • 5.2.2 Expansion in mental health applications
5.3 Future Trends
  • 5.3.1 Gamification in treatment plans
  • 5.3.2 AI-driven therapy solutions
5.4 Impact of Drivers and Restraints

6. North America Digital Therapeutics Market Regional Analysis

6.1 North America Digital Therapeutics Market Overview
6.2 North America Digital Therapeutics Market Revenue 2019-2028 (US$ Million)
6.3 North America Digital Therapeutics Market Forecast Analysis

7. North America Digital Therapeutics Market Analysis – by Application

7.1 Diabetes
  • 7.1.1 Overview
  • 7.1.2 Diabetes: North America Digital Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Cardiovascular Diseases
  • 7.2.1 Overview
  • 7.2.2 Cardiovascular Diseases: North America Digital Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Central Nervous System Disease
  • 7.3.1 Overview
  • 7.3.2 Central Nervous System Disease: North America Digital Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Respiratory Diseases
  • 7.4.1 Overview
  • 7.4.2 Respiratory Diseases: North America Digital Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Smoking Cessation
  • 7.5.1 Overview
  • 7.5.2 Smoking Cessation: North America Digital Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Musculoskeletal Diseases
  • 7.6.1 Overview
  • 7.6.2 Musculoskeletal Diseases: North America Digital Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Digital Therapeutics Market Analysis – by Distribution Channel

8.1 Patients
  • 8.1.1 Overview
  • 8.1.2 Patients: North America Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Providers
  • 8.2.1 Overview
  • 8.2.2 Providers: North America Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Payers
  • 8.3.1 Overview
  • 8.3.2 Payers: North America Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Employers
  • 8.4.1 Overview
  • 8.4.2 Employers : North America Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Digital Therapeutics Market – North America Analysis

9.1 North America
  • 9.1.1 North America Digital Therapeutics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 9.1.1.1 North America Digital Therapeutics Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 US: North America Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.1.1 US: North America Digital Therapeutics Market Breakdown, by Application
    • 9.1.1.1.2 US: North America Digital Therapeutics Market Breakdown, by Distribution Channel
  • 9.1.1.2 Canada: North America Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.2.1 Canada: North America Digital Therapeutics Market Breakdown, by Application
    • 9.1.1.2.2 Canada: North America Digital Therapeutics Market Breakdown, by Distribution Channel
  • 9.1.1.3 Mexico : North America Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.3.1 Mexico : North America Digital Therapeutics Market Breakdown, by Application
    • 9.1.1.3.2 Mexico : North America Digital Therapeutics Market Breakdown, by Distribution Channel

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. North America Digital Therapeutics Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Propeller Health (ResMed)
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Canary Health
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Noom, Inc
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 2Morrow, Inc.
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Teladoc Health, Inc.
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 Welldoc, Inc.
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Fitbit, Inc.
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 Omada Health, Inc.
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 MANGO HEALTH
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
12.10 Pear Therapeutics, Inc.
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - North America Digital Therapeutics Market

  1. Propeller Health (ResMed)
  2. Canary Health
  3. Noom, Inc
  4. 2Morrow, Inc.
  5. Teladoc Health, Inc.
  6. Welldoc, Inc.
  7. Fitbit, Inc.
  8. Omada Health, Inc.
  9. MANGO HEALTH
  10. Pear Therapeutics, Inc.
north-america-digital-therapeutics-market